Pluripotent stem cell applications for regenerative medicine.

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Gene Therapy

Background:

• Human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) are key sources for cell-based therapies.
• Pluripotent stem cell-based therapies aim to regenerate damaged tissues and treat degenerative diseases.

Purpose of the Study:

• To review the current clinical trial status of hESC and hiPSC-derived therapeutic cells.
• To discuss the integration of gene therapy with pluripotent stem cells.
• To identify challenges hindering the widespread clinical adoption of these therapies.

Main Methods:

• Review of current clinical trials involving hESC and hiPSC-derived cell products.
• Analysis of gene-editing technologies like CRISPR/Cas9 for therapeutic applications.
• Discussion of safety and efficacy concerns in pluripotent stem cell therapy.

Main Results:

• Early clinical data indicate safety for hESC/hiPSC-derived cells in retinal repair and spinal cord injury.
• Ongoing studies are evaluating treatments for cardiac injury and diabetes.
• CRISPR/Cas9 gene editing offers precise correction of genetic defects.
• Combined cell and gene therapy presents a potential curative strategy for genetic and degenerative diseases.

Conclusions:

• Human pluripotent stem cells represent a significant advancement in regenerative medicine.
• These cells hold potential for developing novel treatments for various genetic and degenerative conditions.
• Addressing safety and efficacy concerns is crucial for clinical translation.